M33 Growth

Co-founder and Managing Director of M33 Growth who has led investments in companies such as The Oncology Institute, Acclivity Health, and YAPI. Previously spent over a decade as a Partner at General Catalyst; graduated magna cum laude from Yale.

Co-founder of M33 Growth focused on partnering with growth-oriented vertical application software companies. Previously held sales, marketing, investing, and portfolio operations roles at companies including Illumio, Tesla, and firms General Catalyst and Valor Equity Partners; graduate of Notre Dame and Harvard Business School.

Value Creation Partner at M33 Growth focused on go-to-market strategy. Previously Director of Sales Strategy at Pegasystems, with prior roles at ClearTrace, Wayfair, and Bain & Company; holds an MBA from Chicago Booth.

Vice President of Value Creation at M33 Growth. Formerly a management consultant at Bain & Company and a U.S. Navy submarine officer; holds an MBA with honors from Harvard Business School.

Vice President at M33 Growth. Began her career at Goldman Sachs, then worked in strategy and operations at UberEats and Redesign Health; graduated from Yale in Applied Mathematics.

Vice President at M33 Growth who has worked with vertical software companies since 2019. Previously worked at Cambridge Associates on fund-level investments; holds an MBA from MIT Sloan.

Vice President at M33 Growth. Previously a software investment banker at Aeris Partners and a consultant/software engineer at Eze Software Group; holds an MBA from MIT Sloan and is a CFA charterholder.

Executive Director at M33 Growth partnering with high-growth enterprise software companies. Began her career investing at Vista Equity Partners and later led post-merger integration at Finastra; board seats include SwiftComply, BFC Software, and GoDocs.

Vice President of Value Creation at M33 Growth. Spent over six years in SaaS operations at Applause, most recently as VP of M&A, with earlier consulting at RSM US; graduate of Colby College.

Principal at M33 Growth. Previously led M&A for Abode Healthcare and was an investor on the healthcare team at Summit Partners, with earlier experience at Lazard; graduate of Notre Dame.

Investor at M33 Growth. Previously worked in Strategy&'s Private Equity Value Creation group advising PE firms and Fortune 500 companies; graduate of the University of Michigan.

Former CEO and current Vice Chairman of The Oncology Institute (NASDAQ: TOI), which he led through its 2021 public listing. Previously a healthcare investor at TA Associates, General Atlantic, and RLH Equity.

Growth Acceleration Specialist at M33 Growth focused on engineering and AI; a software engineering leader and Columbia MBA with experience at Spotify and Venmo.

Growth Acceleration Specialist at M33 Growth working on product and AI; independent consultant focused on product strategy and building product management teams.

Growth Acceleration Specialist at M33 Growth focused on engineering and AI, with 20+ years of experience building software and leading teams across industries.

Growth Acceleration Specialist at M33 Growth focused on post-sale/customer success, experienced in building and stabilizing teams during rapid growth.

Investor at M33 Growth. Previously conducted investment due diligence at HarbourVest Partners and underwrote fund-level opportunities at Cambridge Associates; graduate of Ohio State University.

Listed as an M33 Advisor, part of a group of experts across sales, marketing, and scaling operations.

Investor at M33 Growth. Previously worked in PwC's Deals Transformation practice in Life Sciences and Pharma; graduate of Boston College.

Investor at M33 Growth. Previously a software investment banker at Aeris Partners working across vertical application markets; graduate of Boston College.

Head of Talent at M33 Growth. Previously led People and Talent functions at venture-backed startups including MANTL and ValuePenguin, specializing in executive hiring and organizational design.

Investor at M33 Growth. Previously a private equity associate at BV Investment Partners and an investment banker at Shea & Company focused on software M&A; graduate of Northeastern University.

CFO of M33 Growth, previously Controller at Solamere Capital and a manager at PricewaterhouseCoopers in audit and assurance. Holds finance and accounting degrees from Tulane and is a CPA.

Operating Partner (Growth Acceleration Specialist) at M33 Growth who has led multiple successful exits as a CEO, investor, and board member.

Investor at M33 Growth. Previously an M&A investment banker at Morgan Stanley across multiple sectors; graduate of Yale in Biomedical Engineering.

Growth Acceleration Specialist at M33 Growth focused on marketing, described as a full-stack marketing leader driving strategy, demand, and product marketing.

Investor at M33 Growth focused on companies scaling beyond the 0-to-1 stage. Previously a strategy consultant at L.E.K. Consulting in TMT; graduate of Boston College.

Growth Acceleration Specialist at M33 Growth focused on engineering and AI; a data-centric AI leader who has built and managed high-performing teams globally.